AB-301

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAB-301
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionOrnithine decarboxylase stimulantsGlucagon-like peptide 1 receptor agonistsProtein-tyrosine kinases inhibitors +[4] 
TargetsOrnithine decarboxylaseProtein-tyrosine kinasesGlucagon-like peptide 1 receptor +[4] 
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRezolute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRezolute
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A